AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
14min chapter
Immune Related Adverse Events of Checkpoint Inhibitors
ACR on Air
Treatment Approaches for Immune-Related Adverse Events
Exploring the use of corticosteroids as the primary therapy for immune-related adverse events from checkpoint inhibitors, the chapter discusses challenges in dosing and progression to disease-modifying drugs. It delves into the considerations of immunosuppression timing for anti-tumor responses and the impact of TNF inhibitors on cancer outcomes. Ongoing studies on IL-6 blockade benefits, heterogeneous inflammatory arthritis, and PD-1 drug use in rheumatoid arthritis treatment are also discussed.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode